Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019
NEW YORK, April 23, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019
Synthetic biology defined as the synthesis of artificial or natural components in order to form new artificial living system by re-molding existing biological elements. It aims to attain new preferred functions of artificially modified organisms intended for high yield production of biological systems. Synthetic biology plays an important role in the field of life sciences by developing cheap synthesis procedures. Increasing scientific research coupled with introduction of advanced technologies in synthetic biology will drive the growth of this market. The market for synthetic biology is segmented as: by products, by technologies and by applications. Product segment includes core products and enabling products. Core product segment comprises synthetic DNA, synthetic genes, synthetic cells, XNA and chassis organisms. While enabling products are segmented into DNA and oligonucleotide synthesis products.
Synthetic biology, by technologies segment is divided into genome engineering, DNA sequencing, bioinformatics and biological components and integrated systems. Application segment of synthetic biology market includes healthcare, chemicals, agriculture and others. This report covers participation of different organizations of the U.S. and the U.K. for the development of synthetic biology field. In addition, it explains various technological advancements taking place in each of these segments. The report includes market estimations of the global synthetic biology market in terms of value (USD million) for the period 2013 – 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global synthetic biology market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019.
The market is also forecasted in terms of value (USD million) for the period 2013 – 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the synthetic biology market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study which would help in decision making.
Some of the key market players of the global synthetic biology market include Agrivida, Inc., Biosearch Technologies, Inc., DuPont, Inc., Evolva SA, Exxon Mobil Corporation and others. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.
The global synthetic biology market is segmented into the following categories:
Synthetic Biology Market, by Products
Core Products
Synthetic DNA
Synthetic Genes
Synthetic Cells
XNA (Xeno Nucleic Acid)
Chasis Organisms
Enabling Products
DNA Synthesis
Oligonucleotide Synthesis
Synthetic Biology Market, by Technologies
Genome Engineering
DNA Sequencing
Bioinformatics
Biological Components and Integrated Systems
Synthetic Biology Market, by Applications
Healthcare
Chemicals (Including Bio-Fuels)
Agriculture
Others (Biosecurity, R&D, Energy and Environment)
Synthetic Biology Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)
Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations
Chapter 2 Executive Summary
2.1 Market Snapshot: Global Synthetic Biology Market (2012 & 2019)
2.1.1 Global Synthetic Biology Market by Technologies, 2012 (USD Million)
2.2 Comparative Analysis: Global Synthetic Biology Market, By Geography, 2012 and 2019 (Value
Chapter 3 Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Drivers
3.2.1.1 Rising demand for improved drugs and vaccines
3.2.1.2 Advancement in molecular biology
3.2.1.3 Encouragement and participation of government bodies and universities in synthetic biology research
3.2.1.4 Increasing demand of genetically modified crops due to rising population
3.3 Market Restraints
3.3.1 Ethical Issues
3.4 Market Opportunities
3.4.1 Increasing clarity about metabolic pathways and nascent nature of synthetic biology concepts
3.5 Porter's Five Force Analysis
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography
Chapter 4 Global Synthetic Biology Market, by Products
4.1 Introduction
4.1.1 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million)
4.2 Core Products
4.2.1 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million)
4.2.2 Synthetic DNA
4.2.2.1 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million)
4.2.3 Synthetic Genes
4.2.3.1 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million)
4.2.4 Synthetic Cells
4.2.4.1 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million)
4.2.5 XNA (Xeno Nucleic Acid)
4.2.5.1 Global XNA Market Revenue, 2014 – 2019 (USD Million)
4.2.6 Chassis Organisms
4.2.6.1 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million)
4.3 Enabling Products
4.3.1 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million)
4.3.2 DNA Synthesis
4.3.2.1 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million)
4.3.3 Oligonucleotide Synthesis
4.3.3.1 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million)
Chapter 5 Global Synthetic Biology Market, by Technologies
5.1 Introduction
5.1.1 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million)
5.2 Genome Engineering
5.2.1 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
5.3 DNA Sequencing
5.3.1 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
5.4 Bioinformatics
5.4.1 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
5.5 Biological Components and Integrated Systems
5.5.1 Global Biological Components and Integrated Systems in Synthetic Biology Market revenue, 2011 – 2019 (USD Million)
Chapter 6 Global Synthetic Biology Market, by Applications
6.1 Introduction
6.1.1 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million)
6.2 Chemicals
6.2.1 Global Synthetic Biology in Chemicals, Market Revenue, 2011 – 2019 (USD Million)
6.3 Healthcare
6.3.1 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million)
6.4 Agriculture
6.4.1 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million)
6.5 Others (Biosecurity, R&D, Energy and Environment)
6.5.1 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million)
Chapter 7 Global Synthetic Biology Market, by Geography
7.1 Introduction
7.1.1 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million)
7.2 North America
7.2.1 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
7.3 Europe
7.3.1 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
7.4 Asia-Pacific
7.4.1 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
7.5 Rest of the World (RoW)
7.5.1 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
Chapter 8 Competitive Landscape
8.1 Heat Map Analysis for Key Market Players
8.1.1 Amyris, Inc.
8.1.2 DuPont, Inc.
8.1.3 Royal DSM
8.1.4 Evolva Holding
8.1.5 Life Technologies Corporation
8.2 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013
Chapter 9 Recommendations
9.1 Market Strategy for Success
9.1.1 Focus on investing in research and development activities
9.1.2 Strategic alliance, mergers and acquisitions
9.2 Barriers to be Considered
9.2.1 Ethical issues associated with synthetic biology products
Chapter 10 Company Profiles
10.1 Agrivida, Inc.
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.1.5 Recent Developments
10.2 Amyris, Inc.
10.2.1 Company Profile
10.2.2 Financial Overview
10.2.3 Product Portfolio
10.2.4 Business Strategies
10.2.5 Recent Developments
10.3 Algenol Biofuels, Inc.
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.3.5 Recent Developments
10.4 ATG:biosynthetics GmbH
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.4.5 Recent Developments
10.5 Bayer AG
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.5.5 Recent Developments
10.6 Bristol-Myers Squibb
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Product Portfolio
10.6.4 Business Strategies
10.6.5 Recent Developments
10.7 BIONEER CORPORATION
10.7.1 Company Overview
10.7.2 Product Portfolio
10.7.3 Business Strategies
10.7.4 Recent Developments
10.8 Biosearch Technologies, Inc.
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Product Portfolio
10.8.4 Business Strategies
10.8.5 Recent Developments
10.9 CBC Comprehensive Biomarker Center GmbH
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Product Portfolio
10.9.4 Business Strategies
10.9.5 Recent Developments
10.10 Cobalt Technologies
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Product Portfolio
10.10.4 Business Strategies
10.10.5 Recent Developments
10.11 DuPont, Inc.
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Product Portfolio
10.11.4 Business Strategies
10.11.5 Recent Developments
10.12 Evolva SA
10.12.1 Company Overview
10.12.2 Financial Overview
10.12.3 Product Portfolio
10.12.4 Business Strategies
10.12.5 Recent Developments
10.13 Exxon Mobil Corporation
10.13.1 Company Overview
10.13.2 Financial Overview
10.13.3 Product Portfolio
10.13.4 Business Strategies
10.13.5 Recent Developments
10.14 Ginkgo Bioworks
10.14.1 Company Overview
10.14.2 Financial Overview
10.14.3 Product Portfolio
10.14.4 Business Strategies
10.14.5 Recent Developments
10.15 GeneWorks Pty Ltd.
10.15.1 Company Overview
10.15.2 Financial Overview
10.15.3 Product Portfolio
10.15.4 Business Strategies
10.15.5 Recent Developments
10.16 Genomatica, Inc.
10.16.1 Company Overview
10.16.2 Financial Overview
10.16.3 Product Portfolio
10.16.4 Business Strategies
10.16.5 Recent Developments
10.17 GeneScript Corporation
10.17.1 Company Overview
10.17.2 Financial Overview
10.17.3 Product Portfolio
10.17.4 Business Strategies
10.17.5 Recent Developments
10.18 Gevo, Inc.
10.18.1 Company Overview
10.18.2 Financial Overview
10.18.3 Product Portfolio
10.18.4 Business Strategies
10.18.5 Recent Developments
10.19 Green Biologics Limited
10.19.1 Company Overview
10.19.2 Financial Overview
10.19.3 Product Portfolio
10.19.4 Business Strategies
10.19.5 Recent Developments
10.20 New England Biolabs, Inc.
10.20.1 Company Overview
10.20.2 Financial Overview
10.20.3 Product Portfolio
10.20.4 Business Strategies
10.20.5 Recent Developments
10.21 OriGene Technologies, Inc.
10.21.1 Company Overview
10.21.2 Financial Overview
10.21.3 Product Portfolio
10.21.4 Business Strategies
10.21.5 Recent Developments
10.22 REG Life Sciences, LLC
10.22.1 Company Overview
10.22.2 Financial Overview
10.22.3 Product Portfolio
10.22.4 Business Strategies
10.22.5 Recent Developments
10.23 Royal DSM
10.23.1 Company Overview
10.23.2 Financial Overview
10.23.3 Product Portfolio
10.23.4 Business Strategies
10.23.5 Recent Developments
10.24 Thermo Fisher Scientific, Inc.
10.24.1 Company Overview
10.24.2 Financial Overview
10.24.3 Product Portfolio
10.24.4 Business Strategies
10.24.5 Recent Developments
List of Figures
FIG. 1 Synthetic Biology Market Segmentation
FIG. 2 Global Synthetic Biology Market, by Technologies, 2012 (USD Million)
FIG. 3 Comparative Analysis: Global Synthetic Biology Market, by Geography, 2012 and 2019 (Value %)
FIG. 4 Porter's Five Forces Analysis: Global Synthetic Biology Market
FIG. 5 Market Attractiveness Analysis: Global Synthetic Biology Market, by Geography
FIG. 6 Global Synthetic DNA Market Revenue, 2011 – 2019 (USD Million)
FIG. 7 Global Synthetic Genes Market Revenue, 2011 – 2019 (USD Million)
FIG. 8 Global Synthetic Cells Market Revenue, 2013 – 2019 (USD Million)
FIG. 9 Global XNA Market Revenue, 2014 – 2019 (USD Million)
FIG. 10 Global Chassis Organisms Market Revenue, 2015 – 2019 (USD Million)
FIG. 11 Global DNA Synthesis Market Revenue, 2011 – 2019 (USD Million)
FIG. 12 Global Oligonucleotide Synthesis Market Revenue, 2011 – 2019 (USD Million)
FIG. 13 Global Genome Engineering in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 14 Global DNA Sequencing in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 15 Global Bioinformatics in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 16 Global Biological Components and Integrated Systems in Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 17 Global Synthetic Biology in Chemicals Market Revenue, 2011 – 2019 (USD Million)
FIG. 18 Global Synthetic Biology in Healthcare Market Revenue, 2011 – 2019 (USD Million)
FIG. 19 Global Synthetic Biology in Agriculture Market Revenue, 2011 – 2019 (USD Million)
FIG. 20 Global Synthetic Biology in Other Applications Market Revenue, 2011 – 2019 (USD Million)
FIG. 21 North America Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 22 Europe Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 23 Asia-Pacific Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 24 RoW Synthetic Biology Market Revenue, 2011 – 2019 (USD Million)
FIG. 25 Heat Map Analysis of the Synthetic Biology Market, by Key Market Players, 2013
FIG. 26 Amyris, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
FIG. 27 Bayer AG: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 28 Bristol-Myers Squibb: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 29 DuPont, Inc.: Annual Revenue, 2010– 2012 (USD Million)
FIG. 30 Evolva SA: Annual Sales, 2010 – 2012 (USD Million), 1 CHF = 1.13 USD
FIG. 31 Exxon Mobil Corporation: Annual Sales, 2010 – 2012 (USD Billion)
FIG. 32 Gevo, Inc.: Annual Sales, 2010 – 2012 (USD Million)
FIG. 33 Renewable Energy Group, Inc.: Annual Sales, 2011 – 2013 (USD Million)
FIG. 34 Royal DSM: Annual Revenue, 2010– 2012 (USD Million)
FIG. 35 Thermo Fisher Scientific, Inc.: Annual Revenue, 2010 – 2012 (USD Million)
List of Tables
TABLE 1 List of Abbreviations
TABLE 2 Market Snapshot: Global Synthetic Biology Market (2012 & 2019)
TABLE 3 Global Synthetic Biology Market Revenue, by Products, 2011 – 2019 (USD Million)
TABLE 4 Global Core Products Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 5 Global Enabling Products Market Revenue, by Types, 2011 – 2019 (USD Million)
TABLE 6 Global Synthetic Biology Market Revenue, by Technologies, 2011 – 2019 (USD Million)
TABLE 7 Global Synthetic Biology Market Revenue, by Applications, 2011 – 2019 (USD Million)
TABLE 8 U.S. Bio-fuels Pipeline Products, by Organizations
TABLE 9 Developed Drugs and Vaccines Utilizing the Concept of Synthetic Biology
TABLE 10 Global Synthetic Biology Market Revenue, by Geography, 2011 – 2019 (USD Million)
TABLE 11 List of Organizations and their Synthetic Biology Products and Applications
To order this report: Synthetic Biology Market (Synthetic DNA, Synthetic Genes, Synthetic Cells, XNA, Chassis Organisms, DNA Synthesis, Oligonucleotide Synthesis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast,2013 - 2019
http://www.reportlinker.com/p02081797/Synthetic-Biology-Market-Synthetic-DNA-Synthetic-Genes-Synthetic-Cells-XNA-Chassis-Organisms-DNA-Synthesis-Oligonucleotide-Synthesis---Global-Industry-Analysis-Size-Share-Growth-Trends-and-Forecast2013---2019.html
__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article